[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-353427-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-353427-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","post-transplant-malignancies-in-taiwanese-kidney-transplant-recipients-incidence-temporal-trends-and-immunosuppressive-risk-factors-in-a-two-decade-single-center-cohort","Post-transplant malignancies in Taiwanese kidney transplant recipients - incidence, temporal trends, and immunosuppressive risk factors in a two-decade single-center cohort","","Post-transplant malignancies (PTMs) are major late immune-related complications after kidney transplantation, yet long-term Asian evidence integrating immunologic exposures remains limited. This study retrospectively evaluated 1,808 recipients transplanted from 2002–2022 at Taichung Veterans General Hospital, with 1,734 eligible after exclusions. Outcomes assessed PTM incidence, spectrum, latency, temporal trends, survival, and prespecified tacrolimus trough levels and cumulative immunosuppressive burden. PTM incidence was 11.7% with urothelial and liver cancers predominating, and older age and cumulative immunosuppression predicting PTM development.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/post-transplant-malignancies-in-taiwanese-kidney-transplant-recipients-incidence-temporal-trends-and-immunosuppressive-risk-factors-in-a-two-decade-single-center-cohort/353427/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/post-transplant-malignancies-in-taiwanese-kidney-transplant-recipients-incidence-temporal-trends-and-immunosuppressive-risk-factors-in-a-two-decade-single-center-cohort/353427.png","ImageObject",300,407,{"name":42,"@type":43},"CatatanPagi","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the incidence and main types of post-transplant malignancies (PTMs)?","Question",{"text":63,"@type":64},"PTM incidence was 11.7%. Urothelial cancers (bladder 15.8% and upper tract 14.3%) and liver cancers predominated.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did PTM latency and temporal trends change over time?",{"text":68,"@type":64},"One third of PTMs occurred within 5 years, with a median latency of 8.2 years. Bladder cancer declined after 2012 (26.7% vs 11.2%, p=0.010).",{"name":70,"@type":61,"acceptedAnswer":71},"Which factors were associated with PTM development and mortality?",{"text":72,"@type":64},"Older age independently predicted PTM development (HR 1.08 per year). Higher long-term tacrolimus trough levels were independently associated with mortality in both overall and PTM cohorts, and cumulative immunosuppressive burden was linked to PTM development.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},353427,1790193102,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},962090894170,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","TYPE Original Research PUBLISHED 17 August 2026  \nDOI 10.3389/fimmu.2026.1738516  \nOPEN ACCESS  \nEDITED BY  \nCarlo Alﬁeri,  \nUniversity of Milan, Italy  \nREVIEWED BY  \nDulat Bekbolsynov,  \nUniversity of Toledo, United States Wojciech Ciesielski,  \nMedical University of Lodz, Poland  \n*CORRESPONDENCE  \nChun-Kuang Yang  \n[yangck@icloud.com](yangck@icloud.com)[ ](yangck@icloud.com)Shun-Fa Yang  \n[ysf@csmu.edu.tw](ysf@csmu.edu.tw)[ ](ysf@csmu.edu.tw)RECEIVED 03 November 2025 REVISED 12 July 2026 ACCEPTED 31 July 2026 PUBLISHED 17 August 2026  \nCITATION  \nHsieh H-C, Li J-R, Wang SS, Chen C-S, Yang C-K and Yang S-F (2026)  \nPost-transplant malignancies in  \nTaiwanese kidney transplant recipients: incidence, temporal trends, and immunosuppressive risk factors in a two-decade single-center cohort. Front. Immunol. 17:1738516 .  \ndoi: 10.3389/fimmu.2026.1738516  \nCOPYRIGHT  \n© 2026 Hsieh, Li, Wang, Chen, Yang and Yang. This is an open-access article distributed under the terms of the  \nCreative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nPost-transplant malignancies in Taiwanese kidney transplant recipients: incidence, temporal trends, and immunosuppressive risk factors in a two-decade single-center cohort  \nHsiang-Chen Hsieh 1,2,3, Jian-Ri Li 1,2,3,4, Shian Shiang Wang 1,2,3,5, Chuan-Shu Chen 1,2,3, Chun-Kuang Yang 2,6* and Shun-Fa Yang 1,7*  \n1 Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan, 2 Department of Urology, Taichung Veterans General Hospital, Taichung, Taiwan, 3 Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan, 4 Department of Medicine and Nursing, Hungkuang University, Taichung, Taiwan, 5 Department of Applied Chemistry, National Chi Nan University, Nantou, Taiwan, 6 Department of Biological Science and Technology, National Yang Ming Chiao Tung University, Hsinchu, Taiwan, 7 Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan  \nBackground: Post-transplant malignancies (PTMs) remain major late immunerelated complications after kidney transplantation, but long-term Asian data integrating immunologic exposures are limited.  \nMethods: We retrospectively analyzed 1,808 kidney transplant recipients from 2002 to 2022 at Taichung Veterans General Hospital, Taiwan. After exclusions, 1,734 patients were eligible. Outcomes included PTM incidence, spectrum, latency, temporal trends, and survival, with prespeciﬁed analyses of longitudinal tacrolimus trough levels and cumulative immunosuppressive burden.  \nResults: PTM incidence was 11 .7% . Urothelial (bladder 15 . 8%, upper tract 14 .3%) and liver cancers predominated. One third occurred within 5 years with a median latency of 8 . 2 years. Bladder cancer declined after 2012 (26 . 7% vs. 11. 2%, p = 0 . 010) . Older age independently predicted PTM (HR 1 . 08 per year, p \u003C 0 . 001) and mortality (HR 1 . 07 per year, p \u003C 0 . 001) . Higher long-term tacrolimus trough levels were independently associated with mortality in both the overall and PTM cohorts (HR 1 . 24 and 1 .37, both p \u003C 0 . 05) . PTM patients had higher mortality (46 . 3% vs . 30. 6%) with median post-diagnosis survival of 16. 5 months.  \nConclusions: PTMs in Taiwan are frequent and immunologically shaped, with a distinct urothelial and hepatic predominance and a post 2012 decline in bladder cancer plausibly linked to evolving immunosuppression, surveillance, and reduced carcinogen exposure. Older age and cumulative immunosuppressive burden were associated with PTM development, whereas higher long-term tacrolimus trough levels independently predicted mortality, underscoring th","cbCaiseMzexgF6PM","https://ap.wps.com/l/cbCaiseMzexgF6PM","pdf",1970561,13,"English","# Background\n# Methods\n# Results\n## PTM incidence and spectrum\n## Latency, trends, and survival associations\n# Conclusions","[{\"question\":\"What was the incidence and main types of post-transplant malignancies (PTMs)?\",\"answer\":\"PTM incidence was 11.7%. Urothelial cancers (bladder 15.8% and upper tract 14.3%) and liver cancers predominated.\"},{\"question\":\"How did PTM latency and temporal trends change over time?\",\"answer\":\"One third of PTMs occurred within 5 years, with a median latency of 8.2 years. Bladder cancer declined after 2012 (26.7% vs 11.2%, p=0.010).\"},{\"question\":\"Which factors were associated with PTM development and mortality?\",\"answer\":\"Older age independently predicted PTM development (HR 1.08 per year). Higher long-term tacrolimus trough levels were independently associated with mortality in both overall and PTM cohorts, and cumulative immunosuppressive burden was linked to PTM development.\"}]","Post-transplant malignancies in Taiwanese kidney transplant recipients - incidence, temporal trends, and immunosuppressive risk factors in a two-decade single-center cohort | PDF",1790105321,33,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6d7bde853beae7b57c2e63cefc4502d9.webp",983,1389,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/667faacbb73cc1f447a74150165a99cb.webp",982,1388,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4a545cfdf4ee7535061840b39cc56702.webp",981,1386,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e2b42d3657254f75c77486ddf8c13655.webp",980,1385]